Legal & General Group’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.6K Sell
4,131
-4,444
-52% -$20K ﹤0.01% 3038
2025
Q1
$38K Sell
8,575
-26,367
-75% -$117K ﹤0.01% 2763
2024
Q4
$274K Buy
34,942
+1,138
+3% +$8.91K ﹤0.01% 2622
2024
Q3
$445K Buy
33,804
+1,114
+3% +$14.6K ﹤0.01% 2505
2024
Q2
$395K Buy
32,690
+29,379
+887% +$355K ﹤0.01% 2496
2024
Q1
$53.8K Sell
3,311
-359
-10% -$5.84K ﹤0.01% 2771
2023
Q4
$25.1K Buy
3,670
+299
+9% +$2.04K ﹤0.01% 2943
2023
Q3
$18.4K Sell
3,371
-550
-14% -$3K ﹤0.01% 3068
2023
Q2
$26.6K Sell
3,921
-509
-11% -$3.46K ﹤0.01% 2988
2023
Q1
$22.2K Sell
4,430
-11,045
-71% -$55.3K ﹤0.01% 3040
2022
Q4
$75.5K Hold
15,475
﹤0.01% 2875
2022
Q3
$223K Sell
15,475
-5,993
-28% -$86.4K ﹤0.01% 2583
2022
Q2
$325K Buy
21,468
+11,469
+115% +$174K ﹤0.01% 2463
2022
Q1
$119K Hold
9,999
﹤0.01% 2826
2021
Q4
$162K Buy
9,999
+85
+0.9% +$1.38K ﹤0.01% 2793
2021
Q3
$282K Buy
9,914
+5,083
+105% +$145K ﹤0.01% 2580
2021
Q2
$163K Buy
4,831
+303
+7% +$10.2K ﹤0.01% 2591
2021
Q1
$137K Buy
4,528
+227
+5% +$6.87K ﹤0.01% 2531
2020
Q4
$212K Sell
4,301
-41
-0.9% -$2.02K ﹤0.01% 2409
2020
Q3
$166K Sell
4,342
-1,317
-23% -$50.4K ﹤0.01% 2390
2020
Q2
$244K Buy
5,659
+1,137
+25% +$49K ﹤0.01% 2323
2020
Q1
$118K Sell
4,522
-1,077
-19% -$28.1K ﹤0.01% 2369
2019
Q4
$175K Buy
5,599
+2,207
+65% +$69K ﹤0.01% 2427
2019
Q3
$88K Hold
3,392
﹤0.01% 2564
2019
Q2
$78K Buy
3,392
+2,318
+216% +$53.3K ﹤0.01% 2616
2019
Q1
$28K Hold
1,074
﹤0.01% 2970
2018
Q4
$22K Buy
+1,074
New +$22K ﹤0.01% 3043